Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Josefine Schulz, Franziska Kluwe, Gerd Mikus, Robin Michelet & Charlotte Kloft. (2019) Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism. Drug Metabolism Reviews 51:3, pages 247-265.
Read now
Read now
Xingxian Luo, Taifeng Li, Ze Yu, Xuecai Xue, Haiyang Zhao, Na li, Liping Ma, Changqing Yang, Lin Huang & Wanyu Feng. (2019) The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes. Xenobiotica 49:7, pages 753-761.
Read now
Read now
Dan Lou, Xiao Cui, Su-Su Bao, Wei Sun, Wen-He Pan, Meng-Chun Chen, Yao-Yao Dong, Guo-Xin Hu, Rui-Jie Chen & Zhe Wang. (2019) Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats. Drug Development and Industrial Pharmacy 45:4, pages 689-693.
Read now
Read now
Li Wang, Shuanghu Wang, Mengchun Chen, Xinxin Chen, Yuxian Lin, Xiaoxia Hu, Xiangxin Huang, Xiangyu Li & Guoxin Hu. (2015) Inhibitory effect of ketoconazole and voriconazole on the pharmacokinetics of carvedilol in rats. Drug Development and Industrial Pharmacy 41:10, pages 1661-1666.
Read now
Read now
Gaotong Lin, Chenming Wang, Xiangjun Qiu, Zhe Wang, Anyue Han, Tao Xu, Xin Kan & Guoxin Hu. (2014) Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat. Drug Development and Industrial Pharmacy 40:12, pages 1616-1622.
Read now
Read now
Articles from other publishers (39)
Juan Cai & Rongwei Shi. (2023)
Exploration of the binding of antifungal drugs to human
P450 2C9
based on docking and molecular dynamics simulation
. International Journal of Quantum Chemistry 123:14.
Crossref
Crossref
Tianrong Xun, Yan Rong, Bin Lv, Jinfei Tian, Qing Zhang & Xixiao Yang. (2023) Interaction and potential mechanisms between atorvastatin and voriconazole, agents used to treat dyslipidemia and fungal infections. Frontiers in Pharmacology 14.
Crossref
Crossref
Ranita Kirubakaran, David W. Uster, Stefanie Hennig, Jane E. Carland, Richard O. Day, Sebastian G. Wicha & Sophie L. Stocker. (2022) Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients. British Journal of Clinical Pharmacology 89:3, pages 1162-1175.
Crossref
Crossref
Zhi-Ping Jin, Miao Yan, Si-Ze Li, Bao-Qing Wang, Qing Xu, Wei Wu, Xiao-Yu Li, Qian-Zhou Lv & Xiao-Qiang Xiang. (2023) Prediction of the Impact of CYP2C19 Polymorphism on Drug-Drug Interaction between Voriconazole and Tacrolimus Using Physiologically-Based Pharmacokinetic Modelling. Brazilian Journal of Pharmaceutical Sciences 59.
Crossref
Crossref
Yuhao Fu, Ying Li, Yinling Ma, Xueru He, Xuejiao Xun, Yanjun Cui, Liju Fan & Zhanjun Dong. (2022) Effects of voriconazole and fluconazole on the pharmacokinetics of almonertinib in rats by UPLC–MS/MS. Biomedical Chromatography 37:1.
Crossref
Crossref
Xiao Huang, Ying Zhou, Jing Zhang, Hongping Xiang, Hao Mei, Li Liu, Lu Tong, Fang Zeng, Yifei Huang, Hong Zhou & Yu Zhang. (2022)
The importance of
CYP2C19
genotype in tacrolimus dose optimization when concomitant with voriconazole in heart transplant recipients
. British Journal of Clinical Pharmacology 88:10, pages 4515-4525.
Crossref
Crossref
Jignesh Prajapati, Priyashi Rao, Lipi Poojara, Dweipayan Goswami, Dhaval Acharya, Saumya K. Patel & Rakesh M. Rawal. (2021) Unravelling the antifungal mode of action of curcumin by potential inhibition of CYP51B: A computational study validated in vitro on mucormycosis agent, Rhizopus oryzae. Archives of Biochemistry and Biophysics 712, pages 109048.
Crossref
Crossref
Saraswathi Nagaraj, Sivakami Manivannan & Shoba Narayan. (2021) Potent antifungal agents and use of nanocarriers to improve delivery to the infected site: A systematic review. Journal of Basic Microbiology 61:10, pages 849-873.
Crossref
Crossref
Yuki Yamaguchi, Takeshi Akiyoshi, Go Kawamura, Ayuko Imaoka, Mitsue Miyazaki, F. Peter Guengerich, Katsunori Nakamura, Koujirou Yamamoto & Hisakazu Ohtani. (2021) Comparison of the inhibitory effects of azole antifungals on cytochrome P450 3A4 genetic variants. Drug Metabolism and Pharmacokinetics 38, pages 100384.
Crossref
Crossref
Nóra Csikány, Ádám Kiss, Máté Déri, Ferenc Fekete, Annamária Minus, Katalin Tóth, Manna Temesvári, Enikő Sárváry, László Bihari, Zsuzsa Gerlei, László Kóbori & Katalin Monostory. (2020) Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A‐status in liver transplant recipients. British Journal of Clinical Pharmacology 87:4, pages 1790-1800.
Crossref
Crossref
Xingxian Luo, Xuecai Xue, Taifeng Li, Ying Zhang, Lin Huang & Gang Cheng. (2020) Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS. Current Drug Metabolism 21:13, pages 1022-1030.
Crossref
Crossref
Jiake He, Yang Yu, Chenglong Yin, Hailang Liu, Hua Zou, Jingsheng Ma, Wentao Yang, Ye Liu, Lin Zhong & Xijing Chen. (2019) Clinically significant drug‐drug interaction between tacrolimus and fluconazole in stable renal transplant recipient and literature review. Journal of Clinical Pharmacy and Therapeutics 45:2, pages 264-269.
Crossref
Crossref
Takaya Uno, Kyoichi Wada, Kouichi Hosomi, Sachi Matsuda, Megumi Morii Ikura, Hiromi Takenaka, Nobue Terakawa, Akira Oita, Satoshi Yokoyama, Atsushi Kawase & Mitsutaka Takada. (2019) Drug interactions between tacrolimus and clotrimazole troche: a data mining approach followed by a pharmacokinetic study. European Journal of Clinical Pharmacology 76:1, pages 117-125.
Crossref
Crossref
Derek A. DuBay, Lewis Teperman, Kimi Ueda, Andrew Silverman, William Chapman, Angel E. Alsina, Carmelina Tyler & Daniel R. Stevens. (2019) Pharmacokinetics of Once‐Daily Extended‐Release Tacrolimus Tablets Versus Twice‐Daily Capsules in De Novo Liver Transplant. Clinical Pharmacology in Drug Development 8:8, pages 995-1008.
Crossref
Crossref
Kenshiro Hirata, Hiroshi Watanabe, Mariko Toyoda, Ryusei Sugimoto, Komei Ikegami, Tadashi Imafuku, Kotaro Matsuzaka, Shota Ichimizu, Hitoshi Maeda, Sohichi Uekihara, Sachiko Jingami & Toru Maruyama. (2019) Effect of Serum Parathyroid Hormone on Tacrolimus Therapy in Kidney Transplant Patients: A Possible Biomarker for a Tacrolimus Dosage Schedule. Biological and Pharmaceutical Bulletin 42:5, pages 786-791.
Crossref
Crossref
Akira Mimura, Satoshi Yamaori, Noriaki Ikemura, Yoshihiko Katsuyama, Naoki Matsuzawa & Shigeru Ohmori. (2019) Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once‐daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation. Journal of Clinical Pharmacy and Therapeutics.
Crossref
Crossref
Amy L Pasternak, Kelley M Kidwell, Jacqueline M Dempsey, Christina L Gersch, Andrea Pesch, Yihan Sun, James M Rae, Daniel L Hertz & Jeong M Park. (2019) Impact of CYP3A5 phenotype on tacrolimus concentrations after sublingual and oral administration in lung transplant. Pharmacogenomics 20:6, pages 421-432.
Crossref
Crossref
Syed Haris Tasleem & Mitchell S. Cappell. (2019) Voriconazole-Induced Hepatotoxicity Presenting With Severe Hepatic Encephalopathy After Liver Transplantation. ACG Case Reports Journal 6:3, pages e00010.
Crossref
Crossref
Rao Fu, Soichiro Tajima, Kimitaka Suetsugu, Hiroyuki Watanabe, Nobuaki Egashira & Satohiro Masuda. (2018) Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation. Acta Pharmacologica Sinica 40:2, pages 151-159.
Crossref
Crossref
Yong Han, Hong Zhou, Jie Cai, Jun Huang, Jing Zhang, Shao-Jun Shi, Ya-Ni Liu & Yu Zhang. (2019) Prediction of tacrolimus dosage in the early period after heart transplantation: a population pharmacokinetic approach. Pharmacogenomics 20:1, pages 21-35.
Crossref
Crossref
Ahmed M. Alkhunaizi, Ali M. Bazzi, Ali A. Rabaan & Elwaleed A. Ahmed. (2018)
Fusarium
Infection in a Kidney Transplant Recipient Successfully Treated with Voriconazole
. Case Reports in Infectious Diseases 2018, pages 1-4.
Crossref
Crossref
Katalin Monostory. 2018. Organ Donation and Transplantation - Current Status and Future Challenges. Organ Donation and Transplantation - Current Status and Future Challenges.
Liumeng Pan, Liping Lu, Jingpeng Wang, Cunwu Zheng, Yujie Fu, Siyuan Xiao, Yating Jin & Shulin Zhuang. (2017) The fungicide difenoconazole alters mRNA expression levels of human CYP3A4 in HepG2 cells. Environmental Chemistry Letters 15:4, pages 673-678.
Crossref
Crossref
Ryan M. Rivosecchi, Cornelius J. Clancy, Ryan K. Shields, Christopher R. Ensor, Michael A. Shullo, Bonnie A. Falcione, Raman Venkataramanan & M. Hong Nguyen. (2017) Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients. Antimicrobial Agents and Chemotherapy 61:9.
Crossref
Crossref
Takashi Yoshikado, Kazuya Maeda, Hiroyuki Kusuhara, Ken-ichi Furihata & Yuichi Sugiyama. (2017) Quantitative Analyses of the Influence of Parameters Governing Rate-Determining Process of Hepatic Elimination of Drugs on the Magnitudes of Drug-Drug Interactions via Hepatic OATPs and CYP3A Using Physiologically Based Pharmacokinetic Models. Journal of Pharmaceutical Sciences 106:9, pages 2739-2750.
Crossref
Crossref
Ruben Kershenovich, Shany Sherman, Ofer Reiter, Shiran Reiss Huss, Elena Didkovsky, Daniel Mimouni, Emmilia Hodak & Rina Segal. (2017) A Unique Clinicopathological Manifestation of Fungal Infection: A Case Series of Deep Dermatophytosis in Immunosuppressed Patients. American Journal of Clinical Dermatology.
Crossref
Crossref
S Pasupneti, O Manouvakhova, MR Nicolls & JL Hsu. (2017)
Aspergillus
-related pulmonary diseases in lung transplantation
. Medical Mycology 55:1, pages 96-102.
Crossref
Crossref
Andrew G. S. Warrilow, Josie E. Parker, Claire L. Price, W. David Nes, Edward P. Garvey, William J. Hoekstra, Robert J. Schotzinger, Diane E. Kelly & Steven L. Kelly. (2016) The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme. Antimicrobial Agents and Chemotherapy 60:8, pages 4530-4538.
Crossref
Crossref
Chiyo K. Imamura, Kenichi Furihata, Shinichiro Okamoto & Yusuke Tanigawara. (2015) Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole. The Journal of Clinical Pharmacology 56:4, pages 408-413.
Crossref
Crossref
Eunyoung Lee, Zhexue Wu, Jong Cheol Shon & Kwang-Hyeon Liu. (2015) Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner. Drug Metabolism and Disposition 43:8, pages 1250-1253.
Crossref
Crossref
Kazuo Oda, Katsuhiro Yamano & Yukio Otsuka. (2015)
In vitro-in vivo
extrapolations to evaluate the effect of concomitant drugs on tacrolimus (FK506) exposure
. Biopharmaceutics & Drug Disposition 36:5, pages 265-274.
Crossref
Crossref
Abdullah M. Al-Mohizea, Abdul Ahad, Gamal M. El-Maghraby, Fahad I. Al-Jenoobi, Khalid M. AlKharfy & Saleh A. Al-Suwayeh. (2014) Effects of Nigella sativa, Lepidium sativum and Trigonella foenum-graecum on sildenafil disposition in beagle dogs. European Journal of Drug Metabolism and Pharmacokinetics 40:2, pages 219-224.
Crossref
Crossref
Jeroen R.P.M. Strating, Lonneke van der Linden, Lucian Albulescu, Joëlle Bigay, Minetaro Arita, Leen Delang, Pieter Leyssen, Hilde M. van der Schaar, Kjerstin H.W. Lanke, Hendrik Jan Thibaut, Rachel Ulferts, Guillaume Drin, Nina Schlinck, Richard W. Wubbolts, Navdar Sever, Sarah A. Head, Jun O. Liu, Philip A. Beachy, Maria A. De Matteis, Matthew D. Shair, Vesa M. Olkkonen, Johan Neyts & Frank J.M. van Kuppeveld. (2015) Itraconazole Inhibits Enterovirus Replication by Targeting the Oxysterol-Binding Protein. Cell Reports 10:4, pages 600-615.
Crossref
Crossref
Romeo-Gabriel Mihăilă. (2015) Voriconazole and the liver. World Journal of Hepatology 7:13, pages 1828.
Crossref
Crossref
A. G. S. Warrilow, C. M. Hull, J. E. Parker, E. P. Garvey, W. J. Hoekstra, W. R. Moore, R. J. Schotzinger, D. E. Kelly & S. L. Kelly. (2014) The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme. Antimicrobial Agents and Chemotherapy 58:12, pages 7121-7127.
Crossref
Crossref
Cher Y. Enderby, Michael G. Heckman, Colleen S. Thomas & Cesar A. Keller. (2014) Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole: a preliminary prospective study. Clinical Transplantation 28:8, pages 911-915.
Crossref
Crossref
Gregory I. Snell, Glen P. Westall & Miranda A. Paraskeva. (2013) Immunosuppression and Allograft Rejection Following Lung Transplantation: Evidence to Date. Drugs 73:16, pages 1793-1813.
Crossref
Crossref
Rakesh K. Goyal, Kelong Han, Donna A. Wall, Michael A. Pulsipher, Nancy Bunin, Stephan A. Grupp, Sripal R. Mada & Raman Venkataramanan. (2013) Sirolimus Pharmacokinetics in Early Postmyeloablative Pediatric Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation 19:4, pages 569-575.
Crossref
Crossref
Isabel Spriet, Veerle Grootaert, Geert Meyfroidt, Yves Debaveye & Ludo Willems. (2012) Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug–drug interaction. European Journal of Clinical Pharmacology 69:3, pages 737-738.
Crossref
Crossref